Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ascendis Pharma A/S

    NASDAQ: ASND · Real-Time Price · USD
    175.73
    -1.17 (-0.66%)
    At close: Jun 23, 2025, 3:59 PM
    176.00
    0.15%
    After-hours: Jun 23, 2025, 06:40 PM EDT

    Ascendis Pharma A/S Statistics

    Share Statistics

    Ascendis Pharma A/S has 60.37M shares outstanding. The number of shares has increased by 5.7% in one year.

    Shares Outstanding

    n/a
    		 60.37M

    Shares Change (YoY)

    n/a
    		 5.7%

    Shares Change (QoQ)

    n/a
    		 0.14%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 59.94M

    Failed to Deliver (FTD) Shares

    n/a
    		 712

    FTD / Avg. Volume

    n/a
    		 0.14%

    Short Selling Information

    The latest short interest is 3.38M, so 5.58% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.38M

    Short % of Shares Out

    n/a
    		 5.58%

    Short % of Float

    n/a
    		 6.71%

    Short Ratio (days to cover)

    n/a
    		 9.33

    Valuation Ratios

    The PE ratio is -20.36 and the forward PE ratio is 83.27. Ascendis Pharma A/S's PEG ratio is 0.86.

    PE Ratio

    n/a
    		 -20.36

    Forward PE

    n/a
    		 83.27

    PS Ratio

    n/a
    		 21.17

    Forward PS

    n/a
    		 3.2

    PB Ratio

    n/a
    		 -72.81

    P/FCF Ratio

    n/a
    		 -25.02

    PEG Ratio

    n/a
    		 0.86
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Ascendis Pharma A/S.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.17, with a Debt / Equity ratio of -8.1.

    Current Ratio

    n/a
    		 1.17

    Quick Ratio

    n/a
    		 0.84

    Debt / Equity

    n/a
    		 -8.1

    Debt / EBITDA

    n/a
    		 -2.95

    Debt / FCF

    n/a
    		 -2.78

    Interest Coverage

    n/a
    		 -4.26

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $357,562.44

    Profits Per Employee

    n/a
    		 $-371,764.01

    Employee Count

    n/a
    		 1,017

    Asset Turnover

    n/a
    		 0.31

    Inventory Turnover

    n/a
    		 0.15

    Taxes

    Income Tax

    n/a
    		 4.84M

    Effective Tax Rate

    n/a
    		 -1.3%

    Stock Price Statistics

    The stock price has increased by 38.11% in the last 52 weeks. The beta is 0.36, so Ascendis Pharma A/S's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.36

    52-Week Price Change

    n/a
    		 38.11%

    50-Day Moving Average

    n/a
    		 163.58

    200-Day Moving Average

    n/a
    		 143.64

    Relative Strength Index (RSI)

    n/a
    		 60.02

    Average Volume (20 Days)

    n/a
    		 496,961

    Income Statement

    In the last 12 months, Ascendis Pharma A/S had revenue of 363.64M and earned -378.08M in profits. Earnings per share was -6.53.

    Revenue

    n/a
    		 363.64M

    Gross Profit

    n/a
    		 319.38M

    Operating Income

    n/a
    		 -278.76M

    Net Income

    n/a
    		 -378.08M

    EBITDA

    n/a
    		 -290.02M

    EBIT

    n/a
    		 -307.74M

    Earnings Per Share (EPS)

    n/a
    		 -6.53
    Full Income Statement

    Balance Sheet

    The company has 559.54M in cash and 856.62M in debt, giving a net cash position of -297.07M.

    Cash & Cash Equivalents

    n/a
    		 559.54M

    Total Debt

    n/a
    		 856.62M

    Net Cash

    n/a
    		 -297.07M

    Retained Earnings

    n/a
    		 n/a

    Total Assets

    n/a
    		 1.06B

    Working Capital

    n/a
    		 35.98M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -306.2M and capital expenditures -1.43M, giving a free cash flow of -307.62M.

    Operating Cash Flow

    n/a
    		 -306.2M

    Capital Expenditures

    n/a
    		 -1.43M

    Free Cash Flow

    n/a
    		 -307.62M

    FCF Per Share

    n/a
    		 -5.31
    Full Cash Flow Statement

    Margins

    Gross margin is 87.83%, with operating and profit margins of -76.66% and -103.97%.

    Gross Margin

    n/a
    		 87.83%

    Operating Margin

    n/a
    		 -76.66%

    Pretax Margin

    n/a
    		 -102.64%

    Profit Margin

    n/a
    		 -103.97%

    EBITDA Margin

    n/a
    		 -79.76%

    EBIT Margin

    n/a
    		 -76.66%

    FCF Margin

    n/a
    		 -84.6%

    Dividends & Yields

    ASND does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ASND is $212, which is 20.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $212

    Price Target Difference

    n/a
    		 20.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 15
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 4.21

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist